ABMD - Abiomed Non-GAAP EPS of $1.16 beats by $0.11 revenue of $270M beats by $2.33M April, 28 2022 07:02 AM ABIOMED Inc. Abiomed press release (NASDAQ:ABMD): Q4 Non-GAAP EPS of $1.16 beats by $0.11. Revenue of $270M (+11.9% Y/Y) beats by $2.33M. For further details see: Abiomed Non-GAAP EPS of $1.16 beats by $0.11, revenue of $270M beats by $2.33M